Organogenesis Holdings Inc (ORGO) Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024 [Yahoo! Finance]
Organogenesis Holdings Inc. - Class A (ORGO)
Last organogenesis holdings inc. - class a earnings: 3/9 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Adjusted EBITDA : Fell to $42.6 million for FY 2023, reflecting a decrease of $6.7 million year-over-year. Advanced Wound Care Products : Remained the largest revenue contributor despite a 4% decline. 2024 Guidance : Anticipates net revenue growth of 3% to 9% year-over-year, with a focus on product launches and commercial support programs. Warning! GuruFocus has detected 5 Warning Sign with ORGO. On February 29, 2024, Organogenesis Holdings Inc ( NASDAQ:ORGO ), a leader in regenerative medicine, announced its financial results for the fourth quarter and fiscal year 2023. The company, which specializes in advanced wound care and surgical & sports medicine products, experienced a downturn in both quarterly and annual revenue. Organogenesis Holdings Inc released its 8-K filing detailing the financial performance and providing guidance for the fiscal year 2024. Financial Performance Overview For the fourth quarter of 2023, Organogenesis reported a net revenue of $99.7 million
Show less
Read more
Impact Snapshot
Event Time:
ORGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORGO alerts
High impacting Organogenesis Holdings Inc. - Class A news events
Weekly update
A roundup of the hottest topics
ORGO
News
- Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024GlobeNewswire
- Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case [Yahoo! Finance]Yahoo! Finance
- Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseGlobeNewswire
- Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Organogenesis Holdings Inc. (NASDAQ: ORGO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $5.00 price target on the stock.MarketBeat
ORGO
Earnings
- 2/29/24 - Beat
ORGO
Sec Filings
- 4/3/24 - Form 8-K
- 4/3/24 - Form 4
- 4/3/24 - Form 4
- ORGO's page on the SEC website